12:00 AM
Mar 20, 2000
 |  BC Week In Review  |  Company News  |  Deals

Axis-Shield, AstraZeneca deal

ASD will develop AZN's ZD 4522 HMG coenzyme A reductase inhibitor, a lipid-lowering statin to prevent heart attacks and...

Read the full 73 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >